Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.23.4
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:    
Net income $ 1,323,909 $ 2,004,860
Adjustments to reconcile net income to net cash provided by operating activities:    
Impairment of goodwill and purchased intangible assets 219,000 0
Depreciation and amortization 201,466 205,446
Loss on extinguishment of debt 0 13,286
Unrealized foreign exchange gain and other (24,376) (18,896)
Asset impairment charges 0 9,905
Disposal of non-controlling interest 0 8,270
Stock-based compensation expense 97,392 73,387
Gain on sale of business 0 (29,687)
Deferred income taxes (136,480) (255,116)
Changes in assets and liabilities, net of assets acquired and liabilities assumed in business acquisitions:    
Accounts receivable (53,247) (495,720)
Inventories (159,608) (393,177)
Other assets (112,392) 30,546
Accounts payable 11,037 80,789
Deferred system revenue 232,307 34,587
Deferred service revenue 74,722 30,219
Other liabilities (167,748) 401,136
Net cash provided by operating activities 1,505,982 1,699,835
Cash flows from investing activities:    
Proceeds from sale of assets 5,079 0
Net proceeds from sale of business 0 75,358
Business acquisitions, net of cash acquired 0 (27,144)
Capital expenditures (144,846) (177,994)
Purchases of available-for-sale securities (982,642) (558,165)
Proceeds from sale of available-for-sale securities 15,235 36,755
Proceeds from maturity of available-for-sale securities 628,277 353,391
Purchases of trading securities (66,007) (37,583)
Proceeds from sale of trading securities 64,757 39,482
Proceeds from other investments 0 1,020
Net cash used in investing activities (480,147) (294,880)
Cash flows from financing activities:    
Payment of debt issuance costs 0 (6,515)
Proceeds from revolving credit facility 0 300,000
Repayment of debt 0 (862,250)
Common stock repurchases (893,229) (444,853)
Payment of dividends to stockholders (378,366) (372,192)
Issuance of common stock 48,433 33,908
Tax withholding payments related to vested and released restricted stock units (71,242) (57,550)
Contingent consideration payable and other, net (1,676) (2,500)
Purchase of non-controlling interest 0 (4,295)
Net cash used in financing activities (1,296,080) (1,416,247)
Effect of exchange rate changes on cash and cash equivalents 7,434 (2,139)
Net decrease in cash and cash equivalents (262,811) (13,431)
Cash and cash equivalents at beginning of period 1,927,865 1,584,908
Cash and cash equivalents at end of period 1,665,054 1,571,477
Supplemental cash flow disclosures:    
Income taxes paid, net 605,434 394,464
Interest paid 138,054 73,851
Non-cash activities:    
Contingent consideration payable - financing activities (765) (1,774)
Dividends payable - financing activities 3,985 3,941
Unsettled common stock repurchase - financing activities 10,999 15,975
Accrued purchases of land, property and equipment - investing activities $ 18,312 $ 30,590